Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

BACKGROUND: Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Sandra, Rommel, Denis, Michoux, Nicolas, Lhommel, Renaud, Hanin, François-Xavier, Duprez, Thierry, Machiels, Jean-Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362602/
https://www.ncbi.nlm.nih.gov/pubmed/25810697
http://dx.doi.org/10.2478/raon-2014-0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362602/
https://www.ncbi.nlm.nih.gov/pubmed/25810697
http://dx.doi.org/10.2478/raon-2014-0030

Ejemplares similares